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APLS is a hypercoagulable state that predisposes patients
to arterial and/or venous thromboses that can result in graft
failure [1]. A 2006 consensus conference defined patients
with definite APLS as having at least one laboratory crite-
rion (e.g. persistent, elevated titres of APL) and one clinical
criterion (e.g. deep vein thrombosis, pregnancy compli-
cations) [2]. However, APLS encompasses a wide range
of clinical symptoms [3]. Notably, a subset of patients
manifest thrombotic complications without detectable an-
tiphospholipid titres. These patients are classified as hav-
ing seronegative antiphospholipid syndrome (SNAPS) [2].
This patient’s history of pregnancy complications was sub-
tle, and the absence of LAC and ACA antibodies did not
raise the possibility of APLS at the time of transplanta-
tion. We therefore propose the diagnosis of SNAPS in this
patient. SNAPS increases the risk of graft thrombosis and
necessitates anti-coagulation before and after the transplant
operation [4]. Therefore, a second transplant operation in
this patient would be considered high risk andwould require
peri-operative anti-coagulation [5]. This case highlights the
difficulty of diagnosing ‘seronegative’ APLS within the
current diagnostic guidelines. It also identifies a need for
new diagnostic tests to identify at-risk patients.
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Severe thiamine deficiency complicated by weight loss
protects against renal ischaemia-reperfusion injury in
rats
Sir,
Injury due to reperfusion after prior ischaemia (IRI) is an
important cause of delayed graft function after renal trans-
plantation [1]. Studies in dogs and rats suggest that thi-
Table 1. Transketolase activity and thiamine and thiamine metabolites
Thiamine deficient
Control (n = 11) (n = 8) P-value
TK activity 13.9 (2.4) 7.7 (1.5) <0.001
TPP 81.2 (13.2) 15.7 (6.5) <0.001
TMP 26.2 (4.9) 0.4 (0.4) <0.001
THM 90.2 (15.2) 2.5 (0.8) <0.001
TK activity is expressed as mU/mg protein. TPP, TMP and THM are
expressed as pmol/mg protein.
amine is protective against IRI in heart and brain [2–4].
It has been argued that many organs, including kidneys
are deficient in thiamine at the moment of transplantation
[4]. We aimed to investigate the effect of severe tissue thi-
amine deficiency on ischaemia-reperfusion injury in rat
kidneys.
Male inbred Lewis rats (± 270 g) (Harlan, Zeist, The
Netherlands) were fed with a thiamine-deficient diet (Arie
Blok, Woerden, The Netherlands). The diet only contained
trace amounts of thiamine (0.16 µg/kg, equalling ∼0.04%
of the thiamine content of regular chow). Control animals
were orally supplemented with 400 µg thiamine/day in a
2.5% sucrose solution, whereas the thiamine-deficient ani-
mals only received the same volume of the sucrose solution.
After 4 weeks, ischaemia-reperfusion procedures were per-
formed. Anaesthesia was induced by 5% isoflurane and
maintained on 3% isoflurane. The rats were placed on a ho-
mothermic table to maintain core body temperature at 37◦C
and the left kidney was subjected to 45 min of ischaemia,
followed by reperfusion. Nephrectomy of the contralateral
right kidney was performed during ischaemia of the left
kidney. Kidney tissue samples were snap-frozen and stored
at −80◦C in 4% formalin. Plasma and red blood cells were
also stored at−80◦C.Tissue transketolase activitywasmea-
sured according to the kinetic method of Chamberlain et al.
[5]. Thiamine, thiamine monophosphate and thiamine py-
rophosphate were determined by HPLC with fluorimetric
detection [6]. All experimental procedures were approved
by theCommittee forAnimal Experiments of theUniversity
of Groningen and performed according to the principles of
laboratory animal care.
In the third week of the experiment, growth of the
thiamine-deficient rats was significantly slower than that
in the control rats (12.1 ± 6.3 g versus 21.0 ± 4.7 g, re-
spectively, P = 0.003). In the fourth week, the thiamine-
deficient rats lost weight, whereas the control rats gained
weight (−9.5 ± 8.8 g versus 15.4 ± 5.2 g, respectively,
P < 0.001), resulting in a significant difference in body
weight before ischaemia reperfusion (326 ± 13.8 g ver-
sus 355 ± 22.8 g respectively, P = 0.006). Induction
of thiamine deficiency resulted in significant decreases
in renal biochemical and functional thiamine status at
the moment of ischaemia reperfusion (Table 1). There
was no difference in baseline plasma creatinine concen-
trations prior to ischaemia reperfusion between thiamine-
deficient and control rats (16.7± 1.8µmol/L versus 16.9±
2.4 µmol/L respectively, P = 0.88). At the first day after
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ischaemia-reperfusion, plasma creatinine concentrations
were significantly lower in thiamine-deficient rats than in
control rats (71.7 ± 22.2 versus 162 ± 106, respectively,
P = 0.02).
In this study, we found that thiamine deficiency compli-
cated by weight loss is protective against renal IRI rather
than a factor that increases susceptibility. Interestingly, it is
long known that in hearts prolonged fasting protects against
IRI [7]. To the best of our knowledge our study is the first
to suggest that a similar phenomenon may be present for
the kidney. If future studies confirm that fasting/wasting
protects against IRI in the kidney, this may lead to iden-
tification of new mechanisms and methods for priming of
kidneys for prevention of IRI.
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RET gene mutations are not a common cause of
congenital solitary functioning kidney in adults
Sir,
RET (rearranged during transfection) is a transmembrane
receptor tyrosine kinase. Loss-of-function RET mutations
occur in Hirschsprung disease, while gain-of-function mu-
tations cause multiple endocrine neoplasia type 2 (MEN2)
and familial medullary thyroid carcinoma (FMTC) [1]. In
mice, Ret initiates mouse kidney development by enhanc-
ing ureteric bud outgrowth [2]. Renal agenesis occurs in
mice with homozygous null mutation of either Ret,Gdnf or
Gfra1, the latter two genes, respectively, coding for a key
ligand that activates Ret and a Ret co-receptor [2].
In humans, unilateral renal agenesis occurs in around
0.01% births and results in a solitary functioning kidney,
whereas bilateral renal agenesis and/or severe dysplasia
occurs in a similar frequency and usually leads to neonatal
death [3].
A role for RET in human kidney development was sug-
gested by a report of unilateral renal agenesis in two mem-
bers of a FMTC family with RET mutation [4]. More re-
cently, RETmutations were reported in 7 of 19 fetuses with
bilateral renal agenesis, and in 2 of 10with unilateral agene-
sis and contralateral dysplasia [5]. However, the prevalence
of RET mutations in adults with congenital solitary func-
tioning kidney is unknown.
A cohort of 14 subjects were selected for our current
study. They were living adults born with a solitary func-
tioning kidney, one of whom had two failed pregnancies
with fetuses affected by malformed kidneys. We screened
exons 1–20 and the conserved splice-sites of RET using
direct sequencing. None of the cohort were known to have
Hirschsprung disease or MEN2/FMTC or other recognized
genetic syndrome. We did not identify any mutations in the
14 adults, and thus it is unlikely that RETmutations will be
a common cause of solitary functioning kidney in adults.
Because mutations of hepatocyte nuclear factor 1B have
been reported in the context of solitary functioning kidney
[6], we also screened this gene by sequencing and by dosage
analysis but failed to find mutations. Other genes such
as GDNF and GFRA1 have yet to be elucidated in our
cohort.
Our study was in adults while Skinner et al. [5] studied
fetuses. We therefore suggest that human RET mutations
causing renal disease lead to severe renal failure incom-
patible with postnatal survival. Mutations of nephrogenesis
genes other than RET should be sought to explain human
congenital solitary functioning kidney.
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